Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis.

Ohshimo S, Bonella F, Grammann N, Starke K, Cui A, Bauer PC, Teschler H, Kohno N, Guzman J, Costabel U.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(1):47-53.

PMID:
19960788
2.

Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation.

Ohshimo S, Bonella F, Sommerwerck U, Teschler H, Kamler M, Jakob HG, Kohno N, Guzman J, Costabel U.

J Heart Lung Transplant. 2011 Dec;30(12):1374-80. doi: 10.1016/j.healun.2011.07.010. Epub 2011 Aug 25.

PMID:
21871820
3.

KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis.

Fathi M, Barbasso Helmers S, Lundberg IE.

J Intern Med. 2012 Jun;271(6):589-97. doi: 10.1111/j.1365-2796.2011.02459.x. Epub 2011 Oct 31.

4.

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.

Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, Bando M, Sugiyama Y, Totani Y, Ishizaki T, Ichiyasu H, Suga M, Hamada H, Kohno N.

Respirology. 2006 Mar;11(2):164-8.

PMID:
16548901
5.

Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis.

Nagy B Jr, Nagy B, Fila L, Clarke LA, Gönczy F, Bede O, Nagy D, Újhelyi R, Szabó Á, Anghelyi A, Major M, Bene Z, Fejes Z, Antal-Szalmás P, Bhattoa HP, Balla G, Kappelmayer J, Amaral MD, Macek M Jr, Balogh I.

Chest. 2016 Sep;150(3):661-72. doi: 10.1016/j.chest.2016.04.006. Epub 2016 Apr 19.

PMID:
27105680
6.

Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.

Kumánovics G, Minier T, Radics J, Pálinkás L, Berki T, Czirják L.

Clin Exp Rheumatol. 2008 May-Jun;26(3):414-20.

PMID:
18578962
7.

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedón JC, Pier GB, Weiss ST.

Pediatr Pulmonol. 2007 Mar;42(3):256-62.

8.

Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis.

Ando M, Miyazaki E, Ito T, Hiroshige S, Nureki SI, Ueno T, Takenaka R, Fukami T, Kumamoto T.

Lung. 2010 Jun;188(3):247-52. doi: 10.1007/s00408-009-9223-x. Epub 2010 Jan 12.

PMID:
20066538
9.

Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis.

Kumánovics G, Görbe E, Minier T, Simon D, Berki T, Czirják L.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-138-44. Epub 2014 Apr 28.

PMID:
24773853
10.

Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis.

Janssen R, Sato H, Grutters JC, Bernard A, van Velzen-Blad H, du Bois RM, van den Bosch JM.

Chest. 2003 Dec;124(6):2119-25.

PMID:
14665489
11.

CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases.

Kruit A, Gerritsen WB, Pot N, Grutters JC, van den Bosch JM, Ruven HJ.

Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):138-46.

PMID:
21319596
12.

Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.

Hamada T, Samukawa T, Kumamoto T, Hatanaka K, Tsukuya G, Yamamoto M, Machida K, Watanabe M, Mizuno K, Higashimoto I, Inoue Y, Inoue H.

BMC Pulm Med. 2015 Sep 30;15:110. doi: 10.1186/s12890-015-0105-0. Erratum in: BMC Pulm Med. 2016;16(1):117.

13.

Heart involvement in children and adults with cystic fibrosis: correlation with pulmonary indexes and inflammation markers.

Giacchi V, Rotolo N, Amato B, Di Dio G, Betta P, La Rosa M, Leonardi S, Sciacca P.

Heart Lung Circ. 2015 Oct;24(10):1002-10. doi: 10.1016/j.hlc.2015.03.006. Epub 2015 Mar 24.

PMID:
25911142
14.

Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.

Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM; Scleroderma Lung Study Research Group.

J Rheumatol. 2009 Apr;36(4):773-80. doi: 10.3899/jrheum.080633. Epub 2009 Mar 13.

PMID:
19286849
15.

Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.

Bonella F, Volpe A, Caramaschi P, Nava C, Ferrari P, Schenk K, Ohshimo S, Costabel U, Ferrari M.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Jul;28(1):27-33.

PMID:
21796888
16.

Aortopulmonary collateral flow in cystic fibrosis assessed with phase-contrast MRI.

Fleck R, McPhail G, Szczesniak R, Knowlton J, Radhakrishnan R, Clancy J, Amin R.

Pediatr Radiol. 2013 Oct;43(10):1279-86. doi: 10.1007/s00247-013-2708-z. Epub 2013 May 16.

17.

The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.

Samukawa T, Hamada T, Uto H, Yanagi M, Tsukuya G, Nosaki T, Maeda M, Hirano T, Tsubouchi H, Inoue H.

BMC Pulm Med. 2012 Sep 11;12:55. doi: 10.1186/1471-2466-12-55.

19.

Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.

Al-Salmi QA, Walter JN, Colasurdo GN, Sockrider MM, Smith EO, Takahashi H, Fan LL.

Chest. 2005 Jan;127(1):403-7.

PMID:
15654008
20.

Serum CA 15-3 is increased in pulmonary fibrosis.

Ricci A, Mariotta S, Bronzetti E, Bruno P, Vismara L, De Dominicis C, Laganà B, Paone G, Mura M, Rogliani P, Mastrangeldo M, Sciacchitano S, Saltini C.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(1):54-63.

PMID:
19960789

Supplemental Content

Support Center